Loading clinical trials...
Loading clinical trials...
A Single-Center, Randomized, Double-Blind, Placebo-Controlled Exploratory Clinical Study of Human Umbilical Cord Mesenchymal Stem Cells Combined With Bovine Type I Collagen for Promoting Third-Degree Burn Wound Repair
Conditions
Interventions
HUMSCs combined with bovine type I collagen
bovine type I collagen
+1 more
Locations
1
China
The First Affiliated Hospital of Xinxiang Medical College
Xinxiang, Henan, China
Start Date
April 6, 2026
Primary Completion Date
December 31, 2027
Completion Date
December 31, 2028
Last Updated
April 14, 2026
NCT06992895
NCT07337616
NCT07025408
NCT06760611
Wenjie Ren
CONTACT
Lead Sponsor
The First Affiliated Hospital of Xinxiang Medical College
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions